HIV-infected progressors and long-term non-progressors differ in their capacity to respond to an A-class CpG oligodeoxynucleotide

1. Saez, R.
2. Echaniz, P.
3. De Juan, M.D.
4. Iribarren, J.A.
5. Cuadrado, E.